RCKT Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.